POMDOCTOR Ltd
Close on Oct 19, 2026
About Pomdoctor
Retail-Miscellaneous Retail, SIC 5900
PomDoctor Limited operates a digital healthcare and pharmaceutical platform in China, connecting registered patients with doctors. The company facilitates medical prescription diagnoses, online doctor consultations, and treatments conducted by contracted healthcare professionals. In addition to telehealth services, the platform enables transacting patients to order and purchase pharmaceutical products, medical devices, and health-related items online, supported by requisite pharmaceutical, food, and internet drug information licenses.
The company operates primarily through Guangzhou Qilekang Digital Health Medical Technology Co., Ltd. and its subsidiaries across the People’s Republic of China, maintaining personal information for over one million platform users. PomDoctor Limited is incorporated in the Cayman Islands as an exempted holding company, with its principal executive offices located in Guangzhou, Guangdong Province, China.
Summary of the business section of Pomdoctor's latest annual report, written by StockData.
Company profile
Company
- Legal name
- POMDOCTOR Ltd
- Headquarters
- Guangzhou, China
- Address
- Yongxu Industrial Park, No.19-23, Hejing Rd, Liwan District
- Phone
- 8602062312277
- Website
- 7lk.com
- Employees
- 10,000, Dec 31, 2025
- Industry
- Retail-Miscellaneous Retail
- Incorporated in
- E9
- Fiscal year ends
- December 31
- Auditor
- HYYH CPA. LLC, Baltimore, Maryland
Stock & identifiers
- Ticker
- POM
- Exchange
- Nasdaq
- IPO date
- Oct 9, 2025
- Shares outstanding
- 23M, Dec 31, 2025
- Filer category
- Non-accelerated filer<br>Emerging growth company
- Stock splits
- 1-for-18 reverse, Jun 22, 2026
- SEC CIK
- 1877971
- CUSIP
- 73181R207
- ISIN
- US73181R2076
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Guoji Luo | Vice President, Director | – |
| Zhenyang Shi | Chief Executive Officer, Director | 5,718,884 |
| Li jinfuhua Xu | Chief Financial Officer | 800,000 |
| Dexiang Wei | Vice President | – |
| Wenqing Bao | Director | – |
| Daxue Donnelly Li | Director | – |
| Yuanyuan Crystal Jing | Director | – |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Apr 30, 2026 | Late filing | Notification of late filing |
| Oct 9, 2025 | IPO | Initial public offering priced (424B4 prospectus) |
| Jul 15, 2025 | Listing | Registration of securities on an exchange (Form 8-A) |